-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ry9ETHAl4SE3m/YzhLOP8lb0JHpyMwqXMDRItB9uyyBu3hfIxNkxfGXdLnDW/iy1 Hvywoy4a8us77eyEV4jR8g== 0000000000-05-059307.txt : 20060818 0000000000-05-059307.hdr.sgml : 20060818 20051123134932 ACCESSION NUMBER: 0000000000-05-059307 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20051123 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: TIDEL TECHNOLOGIES INC CENTRAL INDEX KEY: 0000842695 STANDARD INDUSTRIAL CLASSIFICATION: CALCULATING & ACCOUNTING MACHINES (NO ELECTRONIC COMPUTERS) [3578] IRS NUMBER: 752193593 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 5847 SAN FELIPE STE 900 STREET 2: SAN FELIPE PLZ CITY: HOUSTON STATE: TX ZIP: 77057 BUSINESS PHONE: 7137838200 MAIL ADDRESS: STREET 1: 5847 SAN FELIPE STREET 2: SUITE 900 CITY: HOUSTON STATE: TX ZIP: 77057 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 19920703 PUBLIC REFERENCE ACCESSION NUMBER: 0001140361-05-009823 LETTER 1 filename1.txt Mail Stop 4561 November 23, 2005 Mr. Mark K. Levenick Interim Chief Executive Officer Tidel Technologies Inc. 2900 Wilcrest Drive, Suite 205 Houston, TX 77042 Re: Tidel Technologies, Inc. Revised Preliminary Proxy Statement on Schedule 14A Filed on October 28, 2005 Form 10-K for the years ended 2004 and 2003 Forms 10-Q for the periods ended December 31, 2004, March 31 and June 30, 2005 Dear Mr. Levenick: We have reviewed your response to our letter dated November 22, 2005, as well as the proposed revisions to the disclosure in the above-cited periodic reports relating to the disclosure controls and procedures and have the following comments. 1. We note your response to prior comment 2 and reissue that comment. Please explain to us in reasonable detail the factors you considered in concluding that none of the significant deficiencies in your internal controls and procedures constituted a material weakness. For example, please tell us whether any members of executive management overrode established credit policies, and if so to what extent, and how this did or did not affect your annual or interim financial statements or how you concluded that there was not more than a remote likelihood that this would have resulted in a material misstatement to the financial statements. As another example, tell us the "mitigating controls" that were in place. 2. We remind you that all correspondence must be filed on EDGAR. Please ensure that you file your response letter dated November 22, 2005, as well as any further correspondence relating to the above cited issues. Please direct any questions you may have to Anne Nguyen at (202) 551- 3611 or Kathleen Collins at (202) 551-3499. If you still require further assistance, please contact the undersigned at (202) 551- 3735. Sincerely, Barbara C. Jacobs Assistant Director ?? ?? ?? ?? Mr. Mark K. Levenick Tidel Technologies Inc. November 23, 2005 Page 1 -----END PRIVACY-ENHANCED MESSAGE-----